FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Mayne Pharma Group Limited Stock AnalysisComprehensive stock analysis for Mayne Pharma Group Limited (MAYNF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMAYNF
MAYNF
Mayne Pharma Group Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MAYNF
Home🔹Stocks🔹Mayne Pharma Group Limited

Mayne Pharma Group Limited

MAYNF•OTC

Mayne Pharma Group Limited

MAYNF•OTC
Market cap
$146.24M
Sentiment

Your view on MAYNF

Mkt Cap
$146.24M
Sentiment
Your view
MAYNF
Mayne Pharma Group Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MAYNF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Mayne Pharma Group Limited

Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Aaron Gray
Headquarters
1538 Main North Road, Salisbury South, SA, AU
Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Aaron Gray
Headquarters
1538 Main North Road, Salisbury South, SA, AU
Description

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News